← RAC

RACRACURA ONCOLOGY LTD

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
29 July 2026, 19:12Racure Oncology Techknow Invest PresentationPresentations—03026
29 July 2026, 19:04First HARNESS-1 Patient Safely Treated with RC220Company UpdateMS11001
28 July 2026, 19:12June 2026 Quarterly Activities Report and Appendix 4CQuarterly ReportsMS19004, 19009
13 July 2026, 18:57Notification of cessation of securities - RACOther—06027
9 July 2026, 20:42Racura to Present CPACS Data at GCOS 2026Company Update—11001
6 July 2026, 22:38Racura Oncology New Zealand Investor EventsPresentations—14014
3 July 2026, 18:46Bellberry Ethics Approval Activates New HARNESS Trial SitesCompany UpdateMS11001
2 July 2026, 18:29Notification of cessation of securities - RACOther—06027
25 June 2026, 18:55Racura Treats First Patient in HARNESS-1 Lung Cancer TrialCompany UpdateMS11001
16 June 2026, 22:54Racura Oncology Investor Briefings Perth & AucklandCompany Administration—12008
16 June 2026, 22:36Racura raised $34.3m to Advance Three Oncology TrialsCompany UpdateMS11001
16 June 2026, 22:33Cleansing NoticeSecurities Administration—06018
16 June 2026, 22:27Application for quotation of securities - RACOther—06020
12 June 2026, 00:50Cleansing NoticeSecurities Administration—06018
12 June 2026, 00:49Application for quotation of securities - RACOther—06020
9 June 2026, 18:48Appendix 3Y-Dr Serge ScrofaniDirector Interests—02009
4 June 2026, 22:02Racura Options Raised $24.4mSecurities Administration—06009
4 June 2026, 21:57Notification of cessation of securities - RACOther—06027
4 June 2026, 18:52Proposed issue of securities - RACSecurities Administration—06013
4 June 2026, 18:50Emerging Companies Specialist Invests in RacuraCapital RaisingMS06003
2 June 2026, 01:40Application for quotation of securities - RACOther—06020
30 May 2026, 00:50Application for quotation of securities - RACOther—06020
29 May 2026, 02:43Proposed issue of securities - RACSecurities Administration—06013
29 May 2026, 02:43Racura Enters Underwriting Agreement for OptionsSecurities AdministrationMS06009
28 May 2026, 22:12Appendix 3Y - Dr Daniel TillettDirector Interests—02009
28 May 2026, 22:07Application for quotation of securities - RACOther—06020
26 May 2026, 23:21Appendix 3Y - Dr Daniel TillettDirector Interests—02009
26 May 2026, 23:18Application for quotation of securities - RACOther—06020
21 May 2026, 23:15Appendix 3Y - Dr Daniel TillettDirector Interests—02009
21 May 2026, 23:12Application for quotation of securities - RACOther—06020
21 May 2026, 19:34Racura Oncology Final Option Expiry ReminderCompany Administration—06009, 12008
15 May 2026, 19:04CPACS Trial Cleared to Escalate to Next RC220 Dose LevelCompany UpdateMS11001
14 May 2026, 22:56Appendix 3Y - Dr Daniel TillettDirector Interests—02009
14 May 2026, 22:50Application for quotation of securities - RACOther—06020
8 May 2026, 19:08Racura Oncology Options Expiry ReminderCompany Administration—06009, 12008
7 May 2026, 22:10Appendix 3Y - Dr Daniel TillettDirector Interests—02009
7 May 2026, 22:07Application for quotation of securities - RACOther—06020
4 May 2026, 23:04Application for quotation of securities - RACOther—06020
30 Apr 2026, 23:24Application for quotation of securities - RACOther—06020
30 Apr 2026, 18:50March 2026 Quarterly Activity Report and Appendix 4CQuarterly ReportsMS03002, 19003, 19008
29 Apr 2026, 19:10Racura and Wollongong Uni Granted NSW TechVoucherCompany Administration—12008
24 Apr 2026, 20:40Notification of cessation of securities - RACOther—06027
23 Apr 2026, 22:42Application for quotation of securities - RACOther—06020
22 Apr 2026, 21:13Racura presents MYC silencing data at AACR 2026Company UpdateMS11001
16 Apr 2026, 22:21Application for quotation of securities - RACOther—06020
10 Apr 2026, 00:54Racura Singapore and HK Investor Briefing UpdateCompany Administration—12008
9 Apr 2026, 23:33Application for quotation of securities - RACOther—06020
3 Apr 2026, 00:43Appendix 3Y - Dr Daniel TillettDirector Interests—02009
3 Apr 2026, 00:40Application for quotation of securities - RACOther—06020
1 Apr 2026, 00:53First Patient Recruited to HARNESS-1 Lung Cancer TrialCompany UpdateMS11001
1–50 of 142
1 / 3